Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment [PDF]
The past decade has witnessed ongoing progress in immune therapy to ameliorate human health. As an emerging technique, chimeric antigen receptor (CAR) T-cell therapy has the advantages of specific killing of cancer cells, a high remission rate of cancer ...
Ting Yan, Lingfeng Zhu, Jin Chen
doaj +3 more sources
Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs). [PDF]
Background The host’s immune system develops in equilibrium with both cellular self-antigens and non-self-antigens derived from microorganisms which enter the body during lifetime. In addition, during the years, a tumor may arise presenting to the immune
Luigi Buonaguro +11 more
doaj +3 more sources
Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy. [PDF]
Summary The T cells of the immune system can target tumors and clear solid cancers following tumor-infiltrating lymphocyte (TIL) therapy. We used combinatorial peptide libraries and a proteomic database to reveal the antigen specificities of persistent ...
Dolton G +32 more
europepmc +2 more sources
Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies. [PDF]
Simple Summary Tumor-associated antigens (TAAs) are antigens present in tumor cells, but are also expressed in normal cells. However, TAAs are aberrantly expressed by tumor cells, and can elicit multiple specific immune responses. One key feature of TAAs
Srivastava AK +3 more
europepmc +2 more sources
Acquisition of dying tumor cell-associated antigens is an essential step for the initiation of anti-tumor immune response by conventional type 1 dendritic cells (cDC1).
Nicoletta Caronni +21 more
doaj +2 more sources
mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors. [PDF]
Despite advancements in the successful use of immunotherapy in treating a variety of solid tumors, applications in treating brain tumors have lagged considerably.
Trivedi V +14 more
europepmc +2 more sources
In this study, enzyme-linked immunosorbent assay has been used to examine the frequencies of serum autoantibodies against two candidate tumor-associated antigens intensively selected from the Human Protein Atlas database, in combination with 13 tumor ...
Hao Sun +11 more
doaj +2 more sources
Molecular mimicry between tumor associated antigens and microbiota-derived epitopes [PDF]
Background The gut microbiota profile is unique for each individual and are composed by different bacteria species according to individual birth-to-infant transitions.
Concetta Ragone +7 more
doaj +2 more sources
Expression of tumor-associated antigens in breast cancer subtypes
Objectives: Tumor-associated antigens (TAAs) are frequently overexpressed in several cancer types. The aim of this study was to investigate the expression of TAAs in breast cancer.
Giuseppe Curigliano +9 more
doaj +2 more sources
Targeting Annexin A2 to reactivate tumor-associated antigens presentation and relieve immune tolerance in liver cancer [PDF]
Background Tumor cells manipulate the tumor-associated antigens presentation to escape immune surveillance; however, the molecular mechanism is not exactly clear and the measure to intervene is missing.Methods Annexin A2 was knockout by the CRISPR-Cas9 ...
Min Li +17 more
doaj +2 more sources

